Micah Niphakis received a B.S. in Chemistry from Houghton College and began his graduate studies in 2005 in the Department of Medicinal Chemistry at the University of Kansas with Professor Gunda I. Georg. In 2007, he relocated to the University of Minnesota with Professor Georg where he completed his Ph.D. on the synthesis and biological activity of phenanthropiperidine alkaloids. He then joined the lab of Professor Benjamin F. Cravatt III at the Scripps Research Institute as a Ruth L. Kirschstein NIH postdoctoral fellow. His postdoctoral research focused on the development of serine hydrolase inhibitors and chemical tools to comprehensively map lipid and small molecule interactions in cells. In 2014, he joined Abide Therapeutics as a medicinal chemist and chemical biologist where he is developing chemical tools and techniques to enable serine hydrolase drug discovery.
Wednesday, February 7
2:00 PM – 2:30 PM